RWE: Earnings per share down 33% to €2.15 - Breaking The News
Download our appPlay StoreApp Store

RWE: Earnings per share down 33% to €2.15

EPA/ANGELIKA WARMUTH

RWE AG announced on Thursday that its earnings per share stood at €2.15 in the first quarter of its fiscal 2023, plunging 33% from the same period in 2022.

External revenue, excluding natural gas tax and electricity tax, jumped 18% year over year to €9.41 billion in the opening three-month timeframe in 2023, but net income contracted by 26% to land at €1.6 billion.

"In the first quarter of 2023, we generated 14% more green electricity than in the same period last year. And we have the financial resources to continue investing strongly in organic growth this year. Our project pipeline is well filled, and the forthcoming auctions open up further attractive opportunities for us," Chief Financial Officer Michael Mueller said in a press release.

Related Stocks
RWE
Related News
Unilever's Q1 turnover down 0.9% to €14.8B
Unilever plc revealed on Thursday that its turnover in the first quarter of its fiscal 2025 declined by 0.9% compared to the same period in 2024 to land at €14.8 billion. Underlying sales growth came in at 3%.By segment, Food generated €3.4 billion in turnover, Personal Care and Beauty and Wellbeing both amounted to €3.3 billion in sales, Home Care made up €3 billion, and Ice Cream generated €1.8 billion of revenue."We have started the year with a resilient...
Eni's Q1 net profit down by 11% to €1.41 billion
Eni S.p.A. announced on Thursday that its adjusted net profit in the first quarter of the fiscal year 2025 observed an annual decline of 11% to land at €1.41 billion.The company's sales from operations rose by 9% year-on-year to €5.59 billion. Its total revenues decreased by 0.9% to €22.96 billion, and operating profit by 16% to €1.95 billion. Eni's diluted earnings per share (EPS) dropped by 2.7% to €0.36."Our solid results in Q1 reflect our continued focus on our...
Sanofi's Q1 net sales up by 10.8% to €9.9 billion
Sanofi SA revealed on Thursday that its net sales in the first quarter of the fiscal year 2025 saw an annual rise of 10.8%, 9.7% at the constant exchange rate (CER), to reach €9.9 billion.The company's net income, calculated according to the International Financial Reporting Standards (IFRS), came in at €1.8 billion, and its IFRS earnings per share (EPS) at €1.52. Meanwhile, its business net income increased by 15.9%, or 14.5% at CER, to €2.2 million, and its business...
Roche's Q1 sales up 6% to 15.4 billion Swiss francs
F. Hoffmann-La Roche AG said on Thursday its sales in the first quarter of fiscal 2025 reached 15.4 billion Swiss francs, climbing 7% in Swiss francs and 6% at constant exchange rates (CER) from the same period a year earlier. Sales in the pharmaceuticals division grew 8% at CER to 11.95 billion Swiss francs, while diagnostics division sales amounted to 3.49 Swiss francs, virtually unchanged from the same timeframe in 2024."We had a good start to the year with...

Please observe our Terms of Use. The price information is time delayed to varying extents, but as a rule by 15 minutes or more, according to the regulations of the selected stock exchange and/or licensors and the type of securities.

© 2025 TeleTrader Software GmbH. All rights reserved

This website uses cookies to ensure you get the best experience. Our Terms of Use and Data Protection Policy explain the data we collect, why we collect them, and how we may share them.